Search results for " 2018" in Articles / App Notes
Article
Cytiva Opens Biotechnology Manufacturing Center in UK
27, 2018 press release. In the first half of 2019, the center will start producing a fiber-based chromatography purification platform, which has the potential to improve efficiency in the purification…
Article
A Look at the Affinity Chromatography Landscape
The new resin will be produced at Cytiva’s biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK, which was opened in November 2018.
Article
Ensuring Viral Safety of Viral Vaccines and Vectors
Ensuring Viral Safety of Viral Vaccines and Vectors
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
…
Article
Challenges in Cell Harvesting Prompt Enhancements
Challenges in Cell Harvesting Prompt Enhancements
Higher cell titers and cell densities have posed a challenge to cell harvesting, a crucial step in biologics manufacturing.
By Feliza Mi…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
Aseptic fill/finish is crucial in biopharma manufacturing and is optimized through automated technology.
By Feliza Mirasol
Aseptic filling is a crucial process in biopharmaceutical …
Article
Web Chat June 19: Challenge Cytiva Scientists with Multistep Purification
Event details:
Date: June 19, 2018
Session 1: 09:00 CEST (Berlin), 15:00 CST (Beijing)
Session 2: 8:00 AM PDT (San Francisco), 11:00 AM EDT (New York), 17:00 CEST (Berlin)
Sign up to w…
Article
Understanding Validation and Technical Transfer, Part I
Understanding Validation and Technical Transfer, Part I
This is the first of a series of three articles about validation and technical transfer in the bio-pharmaceutical industry. Part 1 || Part 2 |…
Article
FDA Framework Spurs Advanced Therapies
Lonza will be opening a new and largest-of-its-kind dedicated cell- and gene-manufacturing facility in Houston, TX, early in 2018, in direct response to these concerns.
In addition to manufactu…
Article
Platform Technologies Improve Protein Expression
Regulatory approval of the STEP technology is expected in 2018 at the latest, according to Havenga, with first products on the market using STEP in 2024.
Plant-based expression
Ventria Bio…
Article
Witnessing Major Growth in Next-Generation Antibodies
De Fougerolles expects Ablynx to report results of an on-going Phase III study in the second half of 2017 and be at the approval stage in 2018.
“There are very few limitations when it comes to the…